// App-Quantinova.ai

S246 : A HUMAN BONE MARROW ORGANOID FOR DISEASE MODELLING AND DRUG SCREENING IN BLOOD CANCERS

Researchers

Presenter

  • Abdullah Khan

Principal Investigators

  • Michela Colombo

  • Guanlin Wang

  • Wei Xiong Wen

  • Lauren Murphy

  • Andrew Stone

  • Adam Croft

  • Anindita Roy

  • Sarah Gooding

  • Bethan Psaila

Medical Centers

  • MRC Weatherall Institute of Molecular Medicine, University of Oxford,Oxford,Royaume-uni

  • Healthcare Technologies Institute, School of Chemical Engineering,University of Birmingham,Birmingham,Vereinigtes Königreich

  • School of Dentistry, Institute of Clinical Sciences,University of Birmingham,Birmingham,Royaume-uni

  • School of Dentistry, Institute of Clinical Sciences,University of Birmingham,Birmingham,Royaume-uni

  • Centre for Cardiovascular Sciences, University of Birmingham, Birmingham, United Kingdom

  • Institute of Cardiovascular sciences, University of Birmingham, Birmingham, UK

  • MRC Weatherall Institute of Molecular Medicine, Department of Paediatrics and National Institute of Health Research (NIHR) Oxford Biomedical Research Centre,University of Oxford,Oxford,Royaume-uni

  • IGF Group, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom

  • Healthcare Technologies Institute, School of Chemical Engineering,University of Birmingham,Birmingham,Vereinigtes Königreich

  • Rheumatology Research Group, Institute of Inflammation and Ageing,University of Birmingham,Birmingham,Vereinigtes Königreich

  • MRC Weatherall Institute of Molecular Medicine, University of Oxford,Oxford,Royaume-uni

  • Institute of Cardiovascular Sciences,University of Birmingham,Birmingham,Vereinigtes Königreich

  • Vascular Biology Program, Boston Children's Hospital, Department of Surgery,Harvard Medical School,Boston,États-unis

  • MRC Weatherall Institute of Molecular

  • Vascular Biology Program, Boston Children's Hospital, Department of Surgery,Harvard Medical School,Boston,États-unis

  • Vascular Biology Program, Boston Childre

  • Rheumatology Research Group, Institute of Infla

  • School of Dentistry, Institute of Clinical Sciences,University of Birmingham,Birmingham,Royaume-uni

  • Healthcare Technologies Institute, School of Ch

  • Vascular Biology Program, Boston Children's Hospital, Department of Surgery,Harvard Medical School,Boston,États-unis

  • School of Dentistry, Institute of Clinical Sciences,University of Birmingham,Birmingham,Royaume-uni

  • MRC Weatherall Institute of Molecular Medicine, University of Oxford,Oxford,Vereinigtes Königreich

  • Institute of Cardiovascular Sciences,Universit

  • Rheumatology Research Group, Institute of Inflammation and Ageing, University of Birmingham, UK

  • Institute of Cardiovascular sciences, University of Birmingham, Birmingham, UK

  • Rheumatology Research Group, Institute of Inflammation and Ageing, University of Birmingham, UK

  • Healthcare Technologies Institute, School of Chemical Engineering,University of Birmingham,Birmingham,Vereinigtes Königreich

  • MRC Weatherall Institute of Molecular Medicine, Department of Paediatrics and National Institute of Health Research (NIHR) Oxford Biomedical Research Centre,University of Oxford,Oxford,Royaume-uni

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved